Procedure (Note 1)

Benzyl ((R)-2-(4-(benzyloxy)phenyl)-2-((tert-butoxycarbonyl)amino)acetyl)-D-phenylalaninate (2).
A three-necked, 1-L round-bottomed flask is equipped with an overhead mechanical stirrer in the central neck (Note 2). A septum and a glass stopper are placed in the other two necks. The (R)-bromonitroalkane 2 (1) (8.90 g, 19.7 mmol, 1.0 equiv, 1:1 dr, 99/99% ee), Dphenylalanine benzyl ester hydrochloride (7.10 g, 23.7 mmol, 1.2 equiv), and cesium carbonate (20.64 g, 63.1 mmol, 3.2 equiv) (Note 3) are loaded into the flask. Deionized water (35 mL) and 2-Me-THF (200 mL) (Note 4) are poured into the vessel through the neck bearing the glass stopper. An oxygen balloon is then placed into the septum, and the bright yellow mixture is stirred at maximum speed at room temperature for 7 min (Figure 1a) . N-Iodosuccinimide (4.47 g, 19.7 mmol, 1.0 equiv) (Note 5) is then added in one portion through the neck bearing the glass stopper (dark yellow mixture to brown mixture, Figures 1b-d) . The reaction mixture is stirred for 24 h (Note 6). To quench the reaction, sat. aq. Na 2 S 2 O 3 (50 mL) (Note 7) is poured into the stirring reaction and allowed to stir for 1 h. The mixture is then poured into a 1-L separatory funnel, using EtOAc (50 mL) to rinse the remaining mixture into the funnel. The organic and aqueous layers are separated, and the latter is extracted with EtOAc (2 x 50 mL). The combined organic layers are dried over MgSO 4 (25 g) (Note 8), filtered, and concentrated to a red oil in a 1-L round-bottomed flask by rotary evaporation (40 °C, 110-80 mmHg) (Figure 2a ). The oil is transferred onto a pad of silica (8 cm tall by 7 cm wide), using dichloromethane (10 mL) to retrieve the residual oil and EtOAc:hexanes (1:1) (30 mL) to rinse the flask. The silica is then flushed with EtOAc:hexanes (1:1) (600 mL) into a 1-L round-bottomed flask and is concentrated to a red solid by rotary evaporation (40 °C, 110-80 mmHg). The material is subjected to high vacuum (0.25 mmHg) for 1 h. To the crude solid is added toluene/cyclohexane (3:2) (50 mL) and heated in a warm water bath (70 °C) until all solids are dissolved (Note 9). The flask is then removed from the water bath, capped with a plastic stopper, and allowed to cool to room temperature (25 °C) for 2 h. The flask is cooled to 0 ºC in a freezer for 19 h. The suspension is vacuum filtered through a Büchner funnel (7 cm diameter), fitted with filter paper. Cold cyclohexane (3 x 25 mL) is used to rinse the remaining powder from the round-bottomed flask onto the filter cake (Figure 2b ). The solid is transferred into a tared 100 mL round-bottomed flask and dried by high vacuum (0.25 mmHg) for 12 h to give a beige solid (Figure 2c ) (6.59 g, 56% yield) (Notes 10 and 11). 1 H NMR characterization instead of DMSO-d6 because of the sharpness of the spectrum and the minimal peak overlap with DMF for QNMR. 11. When the procedure was carried out in a half scale reaction with (S)-bromonitroalkane (1) and L-phenylalanine benzyl ester hydrochloride, 3.22 g (55% yield) of the enantiomer of product 2 (benzyl((S)-2-(4-(benzyloxy)phenyl)-2-((tert-butoxycarbonyl)amino)acetyl)-Lphenylalaninate ) was obtained.
Working with Hazardous Chemicals
The procedures in Organic Syntheses are intended for use only by persons with proper training in experimental organic chemistry. All hazardous materials should be handled using the standard procedures for work with chemicals described in references such as "Prudent Practices in the Laboratory" (The National Academies Press, Washington, D. In some articles in Organic Syntheses, chemical-specific hazards are highlighted in red "Caution Notes" within a procedure. It is important to recognize that the absence of a caution note does not imply that no significant hazards are associated with the chemicals involved in that procedure. Prior to performing a reaction, a thorough risk assessment should be carried out that includes a review of the potential hazards associated with each chemical and experimental operation on the scale that is planned for the procedure. Guidelines for carrying out a risk assessment and for analyzing the hazards associated with chemicals can be found in Chapter 4 of Prudent Practices.
The procedures described in Organic Syntheses are provided as published and are conducted at one's own risk. Organic Syntheses, Inc., its Editors, and its Board of Directors do not warrant or guarantee the safety of individuals using these procedures and hereby disclaim any liability for any injuries or damages claimed to have resulted from or related in any way to the procedures herein.
Discussion
Arylglycine α-amino amides are constituent residues within numerous biologically important molecules, including glycopeptide antibiotics (vancomycin, teicoplanin, ristomycin) and α-lactam antibiotics (nocardicins A-G, amoxicillin).
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Arylglycine amino acids can be accessed enantioselectively using chiral auxiliary directed azidation, 4 Sharpless asymmetric dihydroxylation 5 and aminohydroxylation of styrenes, 6 hydrogenation of imino esters, 7 and copper catalyzed diazo insertion into N-H bonds. 8 However, this important motif can be difficult to incorporate in peptides by standard dehydrative amide coupling strategies, which typically involve formation of an active ester intermediate from the amino acid. 9 Upon ester activation, the α-proton is acidified, making epimerization more likely. In the case of active ester intermediates of aryl glycine amino acids, this risk of epimerization is exacerbated by the acidifying effect of the aryl ring.
We addressed this issue in a report using an organocatalyzed azaHenry reaction 10 for the preparation of α -bromo nitroalkanes, and their use in Umpolung Amide Synthesis (UmAS) using an amine, inorganic base, and oxidant 11 (Scheme 1).
Scheme 1. Preparation of Arylglycine Containing Peptides by Enantioselective aza-Henry and Umpolung Amide Synthesis
We hypothesized that the amine and oxidant form an electrophilic species (e.g. an N-halamine) with which the α-bromo nitronate can react. A mechanistic study revealed that the resulting tetrahedral intermediate can collapse in an aerobic or anaerobic fashion to furnish the amide product. 12 Overall, this would constitute a polarity reversal for reactants in the traditional amide bond forming paradigm -the nucleophilic nitronate carbon becomes the amide carbonyl carbon, and the iodamine nitrogen is electrophilic (Umpolung reactivity). This mechanism predicts that stereocenters adjacent to the carbonyl surrogate would not be acidic at any point leading to the amide. This aza-Henry/UmAS strategy has been successfully applied to the preparation of α-oxy amides, 13 aryl glycines, 14 and aliphatic D and L amino acids. 15 Catalytic methods have been developed for the use of substoichiometric N-iodosuccinimide 16 and the use of simple nitroalkanes in UmAS. 17 UmAS has been extended to heterocycle synthesis 18 as well as enlisted in the production of depsipeptide macrocycles. 19 This method directly addresses the challenges of arylglycine synthesis by dehydrative methods, by leveraging the UmAS mechanism to skirt an active ester intermediate, delivering an epimerization-free synthesis of an arylglycine-containing peptide. Given the frequency with which parahydroxy aryl glycine is displayed by natural products, its multigram 
